89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,965,421 | -15.5% | 580,662 | +3.8% | 0.00% | 0.0% |
| Q2 2023 | $10,605,027 | +585.4% | 559,632 | +450.9% | 0.00% | – |
| Q1 2023 | $1,547,246 | +88.9% | 101,592 | +57.9% | 0.00% | – |
| Q4 2022 | $818,870 | +105.7% | 64,326 | -6.3% | 0.00% | – |
| Q3 2022 | $398,000 | +255.4% | 68,677 | +98.1% | 0.00% | – |
| Q2 2022 | $112,000 | -69.8% | 34,676 | -64.8% | 0.00% | – |
| Q1 2022 | $371,000 | -72.3% | 98,567 | -3.7% | 0.00% | – |
| Q4 2021 | $1,339,000 | -33.8% | 102,390 | -0.9% | 0.00% | – |
| Q3 2021 | $2,024,000 | -10.9% | 103,272 | -14.9% | 0.00% | – |
| Q2 2021 | $2,271,000 | -20.8% | 121,414 | +0.2% | 0.00% | -100.0% |
| Q1 2021 | $2,869,000 | -15.8% | 121,145 | -13.4% | 0.00% | 0.0% |
| Q4 2020 | $3,409,000 | +17.1% | 139,885 | +23.4% | 0.00% | 0.0% |
| Q3 2020 | $2,910,000 | +79.7% | 113,399 | +39.5% | 0.00% | – |
| Q2 2020 | $1,619,000 | +49.4% | 81,267 | +89.2% | 0.00% | – |
| Q1 2020 | $1,084,000 | +38.3% | 42,944 | +44.0% | 0.00% | – |
| Q4 2019 | $784,000 | – | 29,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |